John Mendlein leaves Moderna for Flagship; Paul Sekhri to steer first xenotransplantation trials as eGenesis CEO
→ John Mendlein is out at Moderna just a year — a momentous year, no less, that saw Moderna reap …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
